FI941193A7 - IgE-välitteisten yliherkkyysreaktioiden hoitamiseksi tarkoitettu rokote, joka sisältää osan IgE:n vakioalueesta - Google Patents

IgE-välitteisten yliherkkyysreaktioiden hoitamiseksi tarkoitettu rokote, joka sisältää osan IgE:n vakioalueesta

Info

Publication number: FI941193A7
Authority: FI; Finland
Prior art keywords: ige; vaccine; treatment; constant region; containing part
Prior art date: 1991-09-26

Application number

FI941193A

Other languages

English (en)

Swedish (sv)

Other versions

FI107880B (fi

FI941193A0 (fi

Inventor

Lars T Hellman

Original Assignee

Lars T Hellman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-26

Filing date

1994-03-14

Publication date

1994-03-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20383848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI941193(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-03-14 Application filed by Lars T Hellman filed Critical Lars T Hellman

1994-03-14 Publication of FI941193A7 publication Critical patent/FI941193A7/fi

1994-03-14 Publication of FI941193A0 publication Critical patent/FI941193A0/fi

2001-10-31 Application granted granted Critical

2001-10-31 Publication of FI107880B publication Critical patent/FI107880B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/801—Drug, bio-affecting and body treating compositions involving antibody or fragment thereof produced by recombinant dna technology
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/867—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody produced via recombinant dna technology
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FI941193A 1991-09-26 1994-03-14 Menetelmä IgE-välitteisten yliherkkyysreaktioiden hoitamiseksi tarkoitetun rokotteen, joka sisältää osan IgE:n vakioalueesta, valmistamiseksi FI107880B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE9102808		1991-09-26
SE9102808A SE9102808L (sv)	1991-09-26	1991-09-26	Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
SE9200673		1992-09-25
PCT/SE1992/000673 WO1993005810A1 (en)	1991-09-26	1992-09-25	VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS

Publications (3)

Publication Number	Publication Date
FI941193A7 true FI941193A7 (fi)	1994-03-14
FI941193A0 FI941193A0 (fi)	1994-03-14
FI107880B FI107880B (fi)	2001-10-31

Family

ID=20383848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI941193A FI107880B (fi)	1991-09-26	1994-03-14	Menetelmä IgE-välitteisten yliherkkyysreaktioiden hoitamiseksi tarkoitetun rokotteen, joka sisältää osan IgE:n vakioalueesta, valmistamiseksi

Country Status (16)

Country	Link
US (1)	US5653980A (fi)
EP (1)	EP0666760B2 (fi)
JP (2)	JP3583421B2 (fi)
KR (1)	KR100263359B1 (fi)
AT (1)	ATE189960T1 (fi)
AU (1)	AU677573B2 (fi)
CA (1)	CA2117193C (fi)
DE (1)	DE69230733T3 (fi)
DK (1)	DK0666760T4 (fi)
ES (1)	ES2144424T5 (fi)
FI (1)	FI107880B (fi)
GR (1)	GR3033272T3 (fi)
HU (1)	HU218899B (fi)
RU (1)	RU2120805C1 (fi)
SE (1)	SE9102808L (fi)
WO (1)	WO1993005810A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU707083B2 (en) *	1993-08-26	1999-07-01	Bavarian Nordic Inc.	Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes
DK96493D0 (da) *	1993-08-26	1993-08-26	Mouritsen Og Elsner Aps	Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
EP0739214B1 (en) *	1994-01-18	1998-03-18	Genentech, Inc.	A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
FR2715304B1 (fr) *	1994-01-26	1996-04-26	Merieux Serums Vaccins Pasteur	Vaccin anti-allergique.
SK284856B6 (sk) *	1996-03-01	2006-01-05	Novartis Ag	Imunogénna molekula, farmaceutická kompozícia, ligand, spôsob prípravy imunogénnej molekuly a jej použitie
KR100522289B1 (ko) *	1997-04-15	2005-10-19	파멕사 에이/에스	변형된 ＴＮＦα 분자, 이러한 변형된 ＴＮＦα 분자를 코드화하는 ＤＮＡ 및 이러한 변형된 ＴＮＦα 분자 및 ＤＮＡ를 포함하는 백신
US6504013B1 (en)	2000-02-01	2003-01-07	Idexx Laboratories, Inc.	Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
US7393529B2 (en)	1998-04-09	2008-07-01	Idexx Laboratories, Inc.	Methods and compositions for inhibiting binding of IgE to a high affinity receptor
US6734287B1 (en)	1998-04-09	2004-05-11	Idexx Laboratories, Inc.	Specific binding proteins for treating canine allergy
EP1621209A3 (en) *	1998-11-02	2006-04-19	Resistentia Pharmaceuticals AB	Vaccines based on domains of chimeric immunoglobulin E peptides
US6913749B2 (en)	1998-11-02	2005-07-05	Resistentia Pharmaceuticals Ab	Immunogenic polypeptides for inducing anti-self IgE responses
RU2214279C2 (ru) *	1998-11-02	2003-10-20	Резистенция Фармасьютикалс Аб	Усовершенствованные вакцины
US6511814B1 (en)	1999-03-26	2003-01-28	Idexx Laboratories, Inc.	Method and device for detecting analytes in fluids
US6602719B1 (en)	1999-03-26	2003-08-05	Idexx Laboratories, Inc.	Method and device for detecting analytes in fluids
US6887472B2 (en)	2000-08-30	2005-05-03	Pfizer Inc.	Anti-IgE vaccines
JP2003047482A (ja) *	2001-05-22	2003-02-18	Pfizer Prod Inc	非アナフィラキシー誘発性ＩｇＥワクチン
US7604955B2 (en) *	2001-08-13	2009-10-20	Swey-Shen Alex Chen	Immunoglobulin E vaccines and methods of use thereof
AU2003262650B2 (en)	2002-08-14	2009-10-29	Macrogenics, Inc.	FcgammaRIIB-specific antibodies and methods of use thereof
WO2004022094A1 (en) *	2002-09-05	2004-03-18	Resistentia Pharmaceuticals Ab	Allergy vaccines
US20050026881A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) *	2003-07-31	2009-10-22	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
PL2029173T3 (pl)	2006-06-26	2017-04-28	Macrogenics, Inc.	Przeciwciała swoiste dla FC RIIB i sposoby ich zastosowania
US20080118524A1 (en) *	2006-10-20	2008-05-22	Stefan Persson	Anti-IgE Vaccines
CN102245198B (zh) *	2008-12-09	2016-08-17	辉瑞疫苗有限责任公司	IgE CH3肽疫苗
BRPI1008317B1 (pt) *	2009-02-25	2022-05-03	Academia Sinica	Anticorpo cemx-específico ou fragmento de ligação ao antígeno do mesmo, uso do dito anticorpo ou fragmento de ligação ao antígeno para tratar doenças mediadas por ige e uso de um imunogênico ou um análogo com propriedade antigênica similar para induzir uma resposta imune em um paciente
CA2800774A1 (en)	2010-06-07	2011-12-15	Pfizer Vaccines Llc	Ige ch3 peptide vaccine
US9187553B2 (en) *	2012-01-25	2015-11-17	Swey-Shen Chen	Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
WO2013158274A1 (en)	2012-04-20	2013-10-24	Academia Sinica	ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
EP2862873B1 (en) *	2012-06-18	2020-04-29	Nippon Zenyaku Kogyo Co., Ltd.	IgE PEPTIDE VACCINE
US20150004161A1 (en) *	2013-07-01	2015-01-01	University Of Maryland	Fc Coupled Compositions and Methods of Their Use
CN111741768B (zh)	2017-10-31	2024-12-27	合一生技股份有限公司	治疗IgE介导的过敏性疾病

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8616166D0 (en) *	1986-07-02	1986-08-06	Research Corp Ltd	Polypeptide competitor
GB8727045D0 (en) *	1987-11-19	1987-12-23	Research Corp Ltd	Immunoglobulin e competitor
WO1989006138A1 (en) *	1987-12-31	1989-07-13	Tanox Biosystems, Inc.	UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
GB8910263D0 (en) *	1989-05-04	1989-06-21	Ciba Geigy Ag	Monoclonal antibodies specific for an immunoglobulin isotype
GB8913737D0 (en) *	1989-06-15	1989-08-02	Univ Birmingham	A novel anti-allergy treatment

1991
- 1991-09-26 SE SE9102808A patent/SE9102808L/xx not_active Application Discontinuation
1992
- 1992-09-25 HU HU9400845A patent/HU218899B/hu not_active IP Right Cessation
- 1992-09-25 WO PCT/SE1992/000673 patent/WO1993005810A1/en active IP Right Grant
- 1992-09-25 AU AU26765/92A patent/AU677573B2/en not_active Ceased
- 1992-09-25 ES ES92920757T patent/ES2144424T5/es not_active Expired - Lifetime
- 1992-09-25 DK DK92920757T patent/DK0666760T4/da active
- 1992-09-25 RU RU94020409A patent/RU2120805C1/ru not_active IP Right Cessation
- 1992-09-25 US US08/196,227 patent/US5653980A/en not_active Expired - Lifetime
- 1992-09-25 DE DE69230733T patent/DE69230733T3/de not_active Expired - Fee Related
- 1992-09-25 KR KR1019940700753A patent/KR100263359B1/ko not_active Expired - Fee Related
- 1992-09-25 JP JP50558293A patent/JP3583421B2/ja not_active Expired - Fee Related
- 1992-09-25 AT AT92920757T patent/ATE189960T1/de not_active IP Right Cessation
- 1992-09-25 EP EP92920757A patent/EP0666760B2/en not_active Expired - Lifetime
- 1992-09-25 CA CA002117193A patent/CA2117193C/en not_active Expired - Fee Related
1994
- 1994-03-14 FI FI941193A patent/FI107880B/fi active
2000
- 2000-04-19 GR GR20000400955T patent/GR3033272T3/el unknown
2004
- 2004-03-23 JP JP2004084530A patent/JP2004231663A/ja active Pending

Also Published As

Publication number	Publication date
CA2117193A1 (en)	1993-04-01
DE69230733T2 (de)	2000-08-03
WO1993005810A1 (en)	1993-04-01
JP2004231663A (ja)	2004-08-19
GR3033272T3 (en)	2000-09-29
JPH06510768A (ja)	1994-12-01
ES2144424T3 (es)	2000-06-16
EP0666760A1 (en)	1995-08-16
EP0666760B2 (en)	2007-10-10
ES2144424T5 (es)	2008-03-01
DE69230733D1 (de)	2000-04-06
US5653980A (en)	1997-08-05
HU218899B (hu)	2000-12-28
SE9102808L (sv)	1993-03-27
AU2676592A (en)	1993-04-27
DK0666760T4 (da)	2008-01-21
KR100263359B1 (ko)	2000-08-01
CA2117193C (en)	2008-06-17
HUT69782A (en)	1995-09-28
ATE189960T1 (de)	2000-03-15
RU2120805C1 (ru)	1998-10-27
EP0666760B1 (en)	2000-03-01
FI107880B (fi)	2001-10-31
AU677573B2 (en)	1997-05-01
JP3583421B2 (ja)	2004-11-04
DE69230733T3 (de)	2008-05-21
FI941193A0 (fi)	1994-03-14
DK0666760T3 (da)	2000-07-31
SE9102808D0 (sv)	1991-09-26
HU9400845D0 (en)	1994-06-28

Publication	Publication Date	Title
FI941193A7 (fi)	1994-03-14	IgE-välitteisten yliherkkyysreaktioiden hoitamiseksi tarkoitettu rokote, joka sisältää osan IgE:n vakioalueesta
DE68909497D1 (de)	1993-11-04	Knochennagel.
DE59002124D1 (de)	1993-09-09	Haarfestigungsmittel.
NO870002D0 (no)	1987-01-02	Ortopediske/ortosiske splintmaterialer.
DE69003549D1 (de)	1993-11-04	Silicon enthaltendes kosmetisches praeparat.
NO894929D0 (no)	1989-12-08	Verktoey for behandling av undergrunnsbroenner.
EP0635222A3 (en)	1995-03-29	A comb.
FI935093L (fi)	1993-11-17	Hypodermiska naolar
FI905718L (fi)	1991-05-21	Transdermalt medel.
DE3764926D1 (de)	1990-10-18	Schaedlingsbekaempfungs- und pflanzenbehandlungsmittel.
PH25153A (en)	1991-03-27	Benzylurea compounds and pesticides containing them
NO910340L (no)	1991-07-31	Topiske preparater for behandling av menneskenegler.
NO872201D0 (no)	1987-05-26	Stabilisering av multivitamin/sporelement-formuleringer.
FI914995A7 (fi)	1991-10-23	Terapeuttinen aine
DK19893D0 (da)	1993-02-23	Praeparat til nasal behandling
DE69106938D1 (de)	1995-03-09	Haarbehandlungsmittel.
FI892539A7 (fi)	1989-05-24	Immunogena glykopeptider av humant sytomegalovirus.
DE69327153D1 (de)	2000-01-05	Anti-hiv-medikament
NO891956D0 (no)	1989-05-16	Fremgangsmaate ved fremstilling av cyanamid.
FR2632196B1 (fr)	1990-08-24	Descendeur autobloquant
NO166280C (no)	1991-06-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
NO885344D0 (no)	1988-11-30	Defleksjonsaak for katodestraaleroer.
DE68919369D1 (de)	1994-12-15	Orthodontische behandlung.
NO941096D0 (no)	1994-03-25	Vaksine omfattende en del av det konstante område av IgE til behandling av IgE-formidlede allergiske reaksjoner
FR2599239B1 (fr)	1994-04-08	Dispositif d'implantation de cheveux.